These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30715361)

  • 1. New Vaccine Design and Delivery Technologies.
    Kanekiyo M; Ellis D; King NP
    J Infect Dis; 2019 Apr; 219(Suppl_1):S88-S96. PubMed ID: 30715361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
    Ross TM
    J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.
    Krammer F; Palese P
    J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the Development of Universal Influenza Vaccines.
    Sun W; Luo T; Liu W; Li J
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.
    Cho A; Wrammert J
    Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
    Nachbagauer R; Palese P
    Curr Opin Immunol; 2018 Aug; 53():51-57. PubMed ID: 29680576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stalking influenza diversity with a universal antibody.
    Russell CJ
    N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
    Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal influenza vaccines, a dream to be realized soon.
    Zhang H; Wang L; Compans RW; Wang BZ
    Viruses; 2014 Apr; 6(5):1974-91. PubMed ID: 24784572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly protective influenza vaccines: design and production platforms.
    Elbahesh H; Saletti G; Gerlach T; Rimmelzwaan GF
    Curr Opin Virol; 2019 Feb; 34():1-9. PubMed ID: 30497050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.
    Di Mario G; Soprana E; Gubinelli F; Panigada M; Facchini M; Fabiani C; Garulli B; Basileo M; Cassone A; Siccardi A; Donatelli I; Castrucci MR
    Pathog Glob Health; 2017 Mar; 111(2):69-75. PubMed ID: 28081672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.
    Hauck NC; Kirpach J; Kiefer C; Farinelle S; Maucourant S; Morris SA; Rosenberg W; He FQ; Muller CP; Lu IN
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29587397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
    Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.